Open Label Study of NVP+CBV Treatment in Women Who Have Received sdNVP for the pMTCT of HIV

NCT00144157 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

53

Enrollment

INDUSTRY

Sponsor class

Conditions

Acquired Immunodeficiency Syndrome

Interventions

DRUG: Nevirapine
DRUG: Zidovudine
DRUG: 3TC

Sponsor

Boehringer Ingelheim